From: Synovial tissue features associated with poor prognosis in inflammatory arthritis
Total | RA | PsA | UA | P | |
---|---|---|---|---|---|
N | 88 | 26 | 33 | 29 | |
Female, n (%) | 52 (59.77) | 20 (76.92) | 14 (42.42) | 18 (62.06) | 0.026 |
Smoking, n (%) | 13 (14.94) | 5 (19.23) | 3 (9.09) | 5 (17.24) | 0.657 |
Age, mean years (SD) | 50.55 (14.93) | 53.2 (14.2) | 51.4 (13.7) | 47.24 (16.5) | 0.318 |
Disease duration, mean months (SD) | 60.18 (84.12) | 83.3 (113.2) | 60.7 (70.9) | 29.5 (50.8) | 0.581 |
GC, n (%) | 23 (26.43) | 13 (50) | 5 (15.15) | 5 (17.24) | 0.010 |
MTX, n (%) | 31 (35.22) | 11 (42.30) | 12 (36.36) | 8 (27.58) | 0.257 |
LEF, n (%) | 2 (2.27) | 1 (3.86) | 1 (3.06) | - | 0.192 |
SSZ, n (%) | 4 (4.49) | - | - | 4 (13.79) | 0.014 |
Development of bone erosion, n (%) | 19 (21.59) | 7 (26.92) | 4 (12.12) | 8 (27.58) | 0.181 |
ACPA positive, n (%) | 27 (31.03) | 19 (73.07) | - | 8 (27.58) | 0.007 |
RF positive, n (%) | 24 (27.58) | 16 (61.53) | - | 8 (27.58) | 0.001 |
HLB 27 positive, n (%) | 15 (17.24) | - | 9 (27.27) | 6 (20.68) | 0.018 |
DAS28 CRP mean (SD) | 3.00 (0.92) | 3.44 (1.1) | 2.65 (0.6) | 3.00 (0.9) | 0.004 |
DAS28 ERS, mean (SD) | 3.89 (1.19) | 4.31 (1.5) | 3.46 (1) | 4.34 (1.2) | 0.013 |
Initiation of bDMARDS, n (%) | 35 (39.77) | 13 (50) | 10 (30.30) | 12 (41.37) | 0.301 |
BMI, mean (SD) | 34.30 (26.27) | 25 (3.84) | 27.96 (3.70) | 25,09 (3.33) | 0.340 |
Dyslipidemia, n (%) | 17 (19.31) | 3 (11.53) | 11 (33.33) | 3 (10.34) | 0.023 |
Type 2 DM | 15 (17.04) | 2 (7.69) | 10 (30.30) | 3 (10.34) | 0.019 |
HBP | 38 (43.18) | 12 (46.15) | 16 (48.48) | 10 (34.48) | 0.274 |